+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Asthma"

From
From
From
United Arab Emirates Asthma Spacers Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032 - Product Thumbnail Image

United Arab Emirates Asthma Spacers Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032

  • Report
  • April 2024
  • 80 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
Bronchiectasis: Opportunity Assessment and Forecast - Product Thumbnail Image

Bronchiectasis: Opportunity Assessment and Forecast

  • Report
  • May 2024
  • 75 Pages
  • Global
From
From
Asthma in the United States: Understanding the Asthma Patient Experience - Product Thumbnail Image

Asthma in the United States: Understanding the Asthma Patient Experience

  • Report
  • January 2024
  • 152 Pages
  • United States
Respiratory Care Devices Market Overview, 2023-28 - Product Thumbnail Image

Respiratory Care Devices Market Overview, 2023-28

  • Report
  • October 2023
  • 97 Pages
  • Global
From
Loading Indicator

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality. The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers. Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more